Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074406 · ClinicalTrials.gov registry record · NA

Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation

A NA study of Extracorporeal Membrane Oxygenation Complication and Acute Brain Injury, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06074406: Completed NA study of Extracorporeal Membrane Oxygenation Complication and Acute Brain Injury, sponsored by Children's Mercy Hospital Kansas City.

NCT06074406 is a NA study of Extracorporeal Membrane Oxygenation Complication and Acute Brain Injury that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 20 participants, below the 835-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074406, a NA study of Extracorporeal Membrane Oxygenation Complication and Acute Brain Injury, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary object of the study is to further characterize safety and feasibility of low-field bedside MRI in pediatric and neonatal ECMO patients. To perform imaging assessments of an early-stage magnetic resonance imaging (MRI) system on patients using low field magnetic strength. Collect qualitative data from the image assessments to optimize device performance using a low field magnetic resonance imaging device in a simulated use environment; Collect qualitative data from the image assessments using a high field magnetic resonance imaging, computed tomography and ultrasound devices. Generate anonymized image data for post-acquisition evaluation, performance measuring and planning for subsequent study size

Primary Outcome

Measuring the occurrence of adverse events and serious adverse events that occurring during the portable MRI procedure. Adverse events and serious adverse events include (change in mean arterial pressure by 20% increase or decreased measured by the meters of mercury as identified by catheter measurement in patient, a decrease in the ECMO flow rate by 20% measured in milliliters per min by the ECMO machine, decrease in the oxygen saturation by 10% measured by pulse oximetry, dislodgement of the E

Interventions

  • DEVICE Hyperfine

Study Locations (1)

Missouri

  • Children's Mercy Kansas City - Kansas City

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-08-30
Est. Completion 2025-12-30
Phase NA

What the finished NCT06074406 record still lists

NCT06074406 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 835-participant average among 8 other Extracorporeal Membrane Oxygenation Complication trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Extracorporeal Membrane Oxygenation Complication appearing as the primary indexed condition, and to 1 intervention - of which Hyperfine is the first listed.

NCT06074406 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT06074406 about?

NCT06074406 is a clinical study titled "Low-Field Bedside Brain Magnetic Resonance Imaging in Pediatric Extracorporeal Membrane Oxygenation". The primary object of the study is to further characterize safety and feasibility of low-field bedside MRI in pediatric and neonatal ECMO patients. To perform imaging assessments of an early-stage magnetic resonance imaging (MRI) system on patients using low field magnetic strength. Collect qualitat...

What is the current status of trial NCT06074406?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-08-30. Estimated completion is 2025-12-30.

What conditions does trial NCT06074406 study?

This clinical trial studies the following conditions: Extracorporeal Membrane Oxygenation Complication, Acute Brain Injury, Feasibility and Safety of a Low-field MRI.

What interventions are being tested in trial NCT06074406?

The interventions under investigation include: Hyperfine (DEVICE).

Who is sponsoring clinical trial NCT06074406?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074406 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Extracorporeal Membrane Oxygenation Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06074406's enrollment target sits among peer trials

20 7th of 8 higher than 2 of 8 other Extracorporeal Membrane Oxygenation Complication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Extracorporeal Membrane Oxygenation Complication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06074406, the US trial registry maintained by the National Library of Medicine. NCT06074406 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.